Skip to main content

Advertisement

Table 1 Clinical features at baseline and during follow up

From: Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China

  Total Incident
N = 448 N = 448
Baseline, number (%) Follow up, number
Vascular involvement 430 (96.0) 10
 Raynaud phenomenon 424 (94.6) 11
 Fingertip ulcer 128 (28.6) 19
 Loss of finger pad 137 (30.6) 20
 Telangiectasia 153 (34.2) 39
Arthritis 121 (27.0) 66
Muscle involvement 44 (9.8) 11
Pulmonary interstitial disease (ILD)a 358/447 (80.1) 24
Pulmonary arterial hypertension (PAH) 67/359 (18.7) 11
Gastrointestinal involvement 274 (61.2) 38
 Esophagus 243 (54.2) 40
 Gastric 115 (25.7) 20
 Intestinal 67 (15.0) 13
Cardiac involvement 177/397 (44.6) 97/411
 Arrhythmia 16/396 (4.0) 13/412
 LVEF < 50% 1/396 (0.3) 3/411
 Left ventricular diastolic dysfunction 69/396 (17.4) 70/411
 Pericardial effusion 57/396 (14.4) 53/411
 Valvular disease 88/396 (22.2) 70/412
Renal crisis 5 (1.1) 0
Skin Rodnan score 6 (0, 43)
  1. LVEF left ventricular ejection fraction
  2. aPulmonary interstitial disease: one patient diagnosed with silicosis at first visit was excluded